Engineering Cardiovascular Tissue Chips for Disease Modeling and Drug Screening Applications

Area of Science:

• Biomedical Engineering
• Cardiovascular Research
• Drug Discovery

Background:

• Rising drug development costs and limited cardiovascular disease (CVD) drug approvals.
• Current in vitro models lack physiological relevance, and animal models are costly and inaccurate.
• Need for advanced platforms to improve cardiovascular drug safety and efficacy testing.

Purpose of the Study:

• To review recent advances in cardiovascular disease (CVD) modeling using tissue chips.
• To explore the application of tissue chips in drug screening for CVDs.
• To highlight the potential of tissue chips to overcome limitations of traditional models.

Main Methods:

• Review of current literature on tissue chip technology for CVD modeling.
• Analysis of tissue chip applications in in vitro studies of cardiovascular physiology and pathology.
• Evaluation of tissue chips as a platform for high-throughput drug screening.

Main Results:

• Tissue chips provide a biomimetic in vitro environment for modeling cardiovascular tissues.
• These platforms offer mechanistic insights into CVD processes.
• Tissue chips demonstrate significant potential for effective cardiovascular drug screening.

Conclusions:

• Tissue chips represent a promising advancement for in vitro cardiovascular disease modeling.
• They offer a more physiologically relevant and potentially cost-effective alternative to traditional methods.
• Tissue chip technology can accelerate the development of safer and more effective cardiovascular drugs.